Q2 2021 Holdings
Filed 2021-08-13 | 146 holdings | $686.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $291.7M | 850,000 | 42.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $150.5M | 500,000 | 21.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $127.1M | 750,000 | 18.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $27.3M | 500,000 | 4.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $20.1M | 1,646,517 | 2.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $16.8M | 275,000 | 2.4% |
| Adagene Inc(ADAG) | ADS | 005329107 | $13.6M | 1,000,000 | 2.0% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $13.0M | 1,000,000 | 1.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $9.9M | 500,000 | 1.4% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $5.0M | 750,000 | 0.7% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $4.9M | 431,894 | 0.7% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.6M | 100,000 | 0.4% |
| WW Intl Inc(WW6) | COM | 98262P101 | $535.5K | 14,818,300 | 0.1% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $326.7K | 71,178,364 | 0.0% |
| Citigroup Inc(C)Call | COM NEW | 172967424 | $194.6K | 2,750,000 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $183.2K | 5,588,366 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $175.7K | 1,400,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $137.3K | 850,000 | 0.0% |
| General Mtrs Co(GM)Call | COM | 37045V100 | $118.3K | 2,000,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $117.2K | 1,350,000 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $113.1K | 4,633,791 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $104.4K | 1,819,186 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $91.5K | 1,100,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $75.7K | 2,814,191 | 0.0% |
| Intel Corp(INTC)Call | COM | 458140100 | $73.0K | 1,300,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY)Call | COM | 110122108 | $66.8K | 1,000,000 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $63.0K | 750,000 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $60.3K | 797,445 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $57.8K | 2,000,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $56.8K | 1,000,000 | 0.0% |
| Ford MTR Co del(F)Call | COM | 345370860 | $52.0K | 3,500,000 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $51.2K | 2,000,000 | 0.0% |
| Allovir Inc | COM | 019818103 | $45.9K | 2,323,371 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $41.2K | 500,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $40.5K | 250,000 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $39.2K | 500,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $38.8K | 400,000 | 0.0% |
| Oatly Group AB | SPONSORED ADS | 67421J108 | $36.7K | 1,500,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $36.2K | 3,750,000 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $34.6K | 900,000 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $34.0K | 500,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $32.9K | 6,000,000 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $31.6K | 1,317,954 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $31.0K | 800,000 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $30.3K | 2,064,262 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $30.1K | 500,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $29.9K | 800,000 | 0.0% |
| Freeport-Mcmoran Inc(FCX)Call | CL B | 35671D857 | $27.8K | 750,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $27.3K | 350,000 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $25.5K | 994,047 | 0.0% |